Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients

Abstract Background Idiopathic membranous nephropathy (iMN) is recognized as an organ-specific autoimmune disease, mainly caused by anti-PLA2R antibody. This study aimed to study between anti-PLA2R antibody level at diagnosis and the response to tacrolimus (TAC)-based treatment in iMN patients. Meth...

Full description

Bibliographic Details
Main Authors: Bihua Wang, Zhidan Zhu, Feng Huang, Haowen Huang, Luxia Tu, Ying Wang, Linfeng Zheng, Jing Zhou, Xin Wei
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Nephrology
Subjects:
Anti-PLA2R antibody
Idiopathic membranous nephropathy
TAC
Treatment response
Outcome
Online Access:https://doi.org/10.1186/s12882-022-02914-4

Internet

https://doi.org/10.1186/s12882-022-02914-4

Similar Items